|
End-of-day quote
Korea S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 16,670.00 KRW | -1.01% |
|
+11.95% | -70.96% |
| 23/07 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 22/12 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.01% | +11.95% | -4.63% | -15.59% | -70.96% | -65.38% | - | - | - | 189M | |
| +2.41% | +0.29% | -10.89% | +15.78% | +59.66% | +39.41% | +73.38% | +3.89% | - | 64.69B | |
| -0.26% | +6.99% | -7.55% | -1.14% | +8.93% | +9.88% | +77.49% | +217.66% | +5,599.27% | 54.78B | |
| +0.13% | +3.33% | +8.46% | +13.26% | +17.81% | +9.51% | +100.57% | -16.01% | +259.59% | 53.49B | |
| +0.52% | +5.66% | +3.68% | +31.76% | +24.64% | +29.21% | +52.34% | +9.70% | +284.22% | 45.98B | |
| -1.16% | +0.72% | +1.59% | +14.40% | +22.72% | +18.20% | +124.81% | -2.82% | +1,032.91% | 42.94B | |
| -1.84% | +0.33% | -9.41% | -2.83% | +129.44% | +215.14% | +817.88% | +573.61% | - | 40.08B | |
| +0.05% | +0.21% | +9.58% | +9.46% | +12.77% | +18.06% | +48.50% | +9.22% | +166.77% | 33.52B | |
| +0.22% | -4.77% | -13.40% | +17.39% | +45.99% | +26.59% | +0.55% | -61.00% | - | 23.97B | |
| +12.82% | +16.72% | +28.89% | +55.50% | +46.37% | +58.66% | +46.30% | +0.75% | +168.75% | 23.67B | |
| -0.39% | -2.01% | -11.77% | -4.03% | -8.17% | -17.57% | -9.54% | -70.10% | - | 22.13B | |
| +0.20% | -2.09% | -20.71% | -10.91% | -46.39% | -43.12% | +265.17% | +247.36% | +566.43% | 20.39B | |
| +0.88% | +8.27% | +8.92% | +13.83% | +19.45% | +12.48% | +162.20% | +214.95% | +2,161.22% | 18.72B | |
| +2.73% | +17.93% | +20.10% | +57.74% | +77.36% | +81.18% | +102.09% | -17.69% | +353.65% | 16.49B | |
| +1.79% | +9.25% | +9.55% | +28.87% | +38.21% | +40.05% | +88.54% | -15.91% | +110.80% | 16.47B | |
| +0.78% | +3.61% | +11.26% | +16.36% | +48.16% | +62.39% | +209.39% | +199.82% | +480.86% | 15.99B | |
| +0.70% | +5.94% | +5.89% | -3.87% | - | - | - | - | - | 15.98B | |
| -1.28% | -6.83% | +0.43% | +2.20% | +173.78% | +155.82% | +346.24% | +1,376.69% | +747.45% | 14.75B | |
| -0.43% | +9.36% | +4.73% | +8.94% | +0.91% | +1.01% | -23.57% | -35.52% | +125.83% | 14.29B | |
| +4.30% | +6.24% | +2.83% | -6.58% | +22.44% | +9.73% | +540.69% | - | - | 14.03B | |
| Average | +1.08% | +3.48% | +1.88% | +12.03% | +32.80% | +34.80% | +167.95% | +154.98% | +927.52% | 27.63B | |
| Weighted average by Cap. | +0.93% | +3.21% | +0.43% | +13.25% | +37.30% | +39.84% | +157.97% | +121.47% | +1,259.25% |
- Stock Market
- Stocks
- A287840 Stock
- Sector IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
